Announcement on Inclusion of Core Product of Paclitaxel Polymer Micelles for Injection into the Catalogue Of Drugs For Basic National Medical Insurance

About this update from Shanghai Yizhong Pharmaceutical Co. Ltd. Class A

Announcement on Inclusion of Core Product of Paclitaxel Polymer Micelles for Injection into the Catalogue Of Drugs For Basic National Medical InsuranceThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Yizhong Pharmaceutical Co. Ltd. Class A